GenSci145

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GenSci145, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors. [Phase 1]

See pricing